VCs Cite Early Planning As Key To Big Paydays On Device Startups
This article was originally published in The Gray Sheet
Executive Summary
Enteric Medical and Spinal Dynamics Corp. (SDC) exemplify venture capital-backed firms sold to large medical device players for healthy returns on investment dollars, according to panelists at the Wilson Sonsini Goodrich & Rosati medical device meeting in San Jose, Calif. June 18-19
You may also be interested in...
Medtronic’s $270 Mil. SDC Artificial Disc Purchase Supplements Internal R&D
Medtronic will continue its in-house artificial disc R&D program following the acquisition of Bryan cervical disc system developer Spinal Dynamics Corp. (SDC) as part of a two-pronged strategy to develop an alternative to spinal fusion devices for degenerative disc disease
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.